| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2011 | Advances in chitin/chitosan science and their applications | Chen R.-H.; Domard A.; Muzzarelli R.A.A.; Tokura S.; Wang D.-M. | Carbohydrate Polymers | 12 | 14 | |
| 2003 | Antibiotics induce apoptosis of human peritoneal mesothelial cells | CHENG-CHUNG FANG ; Yen C.-J.; Tsai T.-J.; Chen R.-H.; Lee P.-H.; Tomino Y. | Nephrology | 13 | 14 | |
| 2003 | Antibiotics induce apoptosis of human peritoneal mesothelial cells | Fang C.-C.; CHUNG-JEN YEN ; Tsai T.-J.; Chen R.-H.; Lee P.-H.; Tomino Y. | Nephrology | | 14 | |
| 2003 | Antibiotics induce apoptosis of human peritoneal mesothelial cells | Fang C.-C.; Yen C.-J.; Tsai T.-J.; Chen R.-H.; PO-HUANG LEE ; Tomino Y. | Nephrology | | 14 | |
| 2003 | Antibiotics induce apoptosis of human peritoneal mesothelial cells | Fang C.-C.; Yen C.-J.; TUN-JUN TSAI ; Chen R.-H.; Lee P.-H.; Tomino Y. | Nephrology | | 14 | |
| 2013 | CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation | Chang C.-C.; Yang M.-H.; BEEN-REN LIN ; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; Jeng Y.-M.; Chu C.-Y.; Chen R.-H.; Yang P.-C.; Eugene Chin Y.; Kuo M.-L. | Cell Death and Differentiation | 18 | 19 | |
| 2013 | CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation | Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; Jeng Y.-M.; CHIA-YU CHU ; Chen R.-H.; Yang P.-C.; Eugene Chin Y.; Kuo M.-L. | Cell Death and Differentiation | 18 | 19 | |
| 2013 | CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation | Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; YUNG-MING JENG ; Chu C.-Y.; Chen R.-H.; Yang P.-C.; Eugene Chin Y.; Kuo M.-L. | Cell Death and Differentiation | 18 | 19 | |
| 2013 | CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation | Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; Jeng Y.-M.; Chu C.-Y.; Chen R.-H.; PAN-CHYR YANG ; Eugene Chin Y.; Kuo M.-L. | Cell Death and Differentiation | | 19 | |
| 2001 | Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male sprague-dawley rats | Chen C.-C.; Wang H.-J.; Shih H.-C.; Sheen L.-Y. ; Chang C.-T.; Chen R.-H.; Wang T.-Y. | Journal of the Formosan Medical Association | 11 | | |
| 2019 | Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136) | Chang C.-C.; Yang M.-H.; BEEN-REN LIN ; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; Jeng Y.-M.; Chu C.-Y.; Chen R.-H.; Yang P.-C.; Chin Y.E.; Kuo M.-L. | Cell Death and Differentiation | 1 | 0 | |
| 2019 | Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136) | Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; Jeng Y.-M.; CHIA-YU CHU ; Chen R.-H.; Yang P.-C.; Chin Y.E.; Kuo M.-L. | Cell Death and Differentiation | 1 | 0 | |
| 2019 | Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136) | Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; YUNG-MING JENG ; Chu C.-Y.; Chen R.-H.; Yang P.-C.; Chin Y.E.; Kuo M.-L. | Cell Death and Differentiation | 0 | 0 | |
| 2019 | Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136) | Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; Lin S.-K.; Jeng Y.-M.; Chu C.-Y.; Chen R.-H.; PAN-CHYR YANG ; Chin Y.E.; Kuo M.-L. | Cell Death and Differentiation | | 0 | |
| 2002 | DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals | Wang W.-J.; Kuo J.-C.; JANE CHUNG-CHEN YAO ; Chen R.-H. | Journal of Cell Biology | | 129 | |
| 2012 | Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones | Lee C.-C.; Huang K.-F.; Chang D.-M.; Hsu J.-J.; Huang F.-C.; Shih K.-N.; Chen C.-L.; Chen T.-C.; Chen R.-H.; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 16 | 17 | |
| 2010 | A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese | Tsai F.-J.; Yang C.-F.; Chen C.-C.; LEE-MING CHUANG ; Lu C.-H.; Chang C.-T.; Wang T.-Y.; Chen R.-H.; Shiu C.-F.; Liu Y.-M.; Chang C.-C.; Chen P.; Chen C.-H.; Fann C.S.J.; Chen Y.-T.; Wu J.-Y. | PLoS Genetics | 235 | 233 | |
| 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | Huang H.-H.; Chen F.-Y.; WEN-CHIEN CHOU ; Hou H.-A.; Ko B.-S.; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H. | BMC Cancer | 4 | 6 | |
| 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | Huang H.-H.; Chen F.-Y.; Chou W.-C.; Hou H.-A.; Ko B.-S.; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | | | |
| 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | Huang H.-H.; Chen F.-Y.; Chou W.-C.; Hou H.-A.; Ko B.-S.; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; SHANG-JU WU ; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H. | BMC Cancer | | | |
